The metabolic pathway of CYP2J2-EET-sEH plays an essential role in the pathomechanism of fibrosis, while the therapeutic effects of EETs against PF and their specific mechanism are still unclear. The gene discussed is CYP2J2; the disease is pemphigus foliaceus.